ArticleAdvances in nutrition (Bethesda, Md.)2026
Intermittent Fasting and Fat-Free Mass Outcomes in Middle-Aged and Older Adults: A Scoping Review.
Article in Advances in nutrition (Bethesda, Md.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Promise and Uncertainty of Intermittent Fasting for Aging Populations.Advances in nutrition (Bethesda, Md.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intermittent fasting (IF) has gained popularity as a weight-loss strategy. Because muscle mass naturally declines with age, concerns arise about effects on fat-free mass (FFM) in aging populations. The objective of this review was to explore the current evidence on the effects of IF on: 1) FFM in middle-aged and older adults, compared with habitual diet (HD) or continuous energy restriction (CER); and 2) other anthropometric outcomes, functional performance, and quality of life. Three databases were searched, supplemented with snowballing and the clinicaltrials.gov registry. Eligible studies (2000-2025) were randomized controlled trial (RCTs) in adults ≥45 y, with IF lasting ≥4 wk, reporting FFM using validated methods, and excluding participants with disease-related muscle loss. Twenty RCTs (1653 participants; 64% females), primarily involving adults with overweight/obesity, were included. Over the intervention durations studied (commonly ≤12 wk), between-group differences in total FFM were generally small. Findings showed that IF produced reductions in fat mass (FM), body weight (BW), and waist circumference that were comparable with those observed with CER. Reductions in BW and FM were more consistently reported in IF compared with HD. Alternate-day fasting and alternate-day modified fasting were commonly studied and frequently associated with BW and FM reductions, particularly compared with HD. Evidence regarding insulin-related outcomes, dietary protein intake, and combined IF and physical activity interventions was limited and heterogeneous. Functional and quality of life outcomes were rarely assessed. Most studies measured total FFM or lean mass using dual-energy X-ray absorptiometry or bioelectrical impedance analysis; thus, it may not reflect skeletal muscle changes. Collectively, the current evidence does not permit definitive conclusions regarding the impact of IF on FFM preservation, especially in the long-term, in older populations. The findings highlight substantial gaps in study duration and methodological standardization. Longer-term, high-quality trials incorporating standardized muscle health and functional outcomes are needed to clarify the role of IF in strategies for healthy aging.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.